Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

The CLIA-enabling study is when the protocol is established for the actual use of LymPro in the laboratory for which C.L.I.A. status will be approved for LymPro.

My best guess is that considering the time of the year with holidays involved that LymPro will not be C.L.I.A. approved at the initial location until 1Q2015.

Take the time to visit the following site to learn more about CLIA.

http://www.cms.gov/Regulations-and-Guidance/L...ect=/clia/

p.s. Someone may want to contact Gerald to get a more definitive time frame.